SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 2nd, 2024 • Calidi Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 2nd, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _____, 2024, between Calidi Biotherapeutics, Inc. Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).